Literature DB >> 7810804

Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infection.

A J Luty1, J Mayombo, F Lekoulou, R Mshana.   

Abstract

The development of antidisease immunity in children infected with Plasmodium falciparum is thought to be related to their immunologic responses to certain soluble parasite-derived exoantigens. We have assessed both cellular and humoral responses to these antigens in a cross-sectional study of a cohort of Gabonese schoolchildren who live in an area where malaria is holoendemic and perenially transmitted, in an attempt to identify immunologic markers of this early developing protective immunity. Concurrent parasitemia was found to have a significant influence on lymphoproliferative and antibody responses to the exoantigens. Individuals with higher levels of parasitemia had significantly lower proliferative and IgG isotype responses. Higher concentrations of specific IgG1 and IgG3, in particular, were associated with lower or no parasitemia, suggesting a possible protective role for these isotypes, whereas the level of IgM antibodies showed a trend towards higher concentrations in those with parasitemia, perhaps indicative of an exoantigen-induced T cell-independent response. Cytokine responses were unaffected by either the presence or the intensity of parasitemia and were dissociated from both proliferative and antibody response to the exoantigens. However, the mitogen-stimulated production of tumor-necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL)-6 was positively correlated with the corresponding lymphoproliferative responses. At the individual level, mitogen-stimulated TNF-alpha, interferon-gamma, IL-2, and IL-6 responses were positively correlated, as were mitogen- and exoantigen-induced TNF-alpha. The results are discussed in the light of current knowledge of immune responses to the exoantigens and the development of protective immunity to P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810804     DOI: 10.4269/ajtmh.1994.51.720

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait.

Authors:  F Ntoumi; C Rogier; A Dieye; J F Trape; P Millet; O Mercereau-Puijalon
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

2.  Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum.

Authors:  J D Kurtis; D E Lanar; M Opollo; P E Duffy
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project.

Authors:  O H Branch; S Takala; S Kariuki; B L Nahlen; M Kolczak; W Hawley; A A Lal
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Distinct patterns of blood-stage parasite antigens detected by plasma IgG subclasses from individuals with different level of exposure to Plasmodium falciparum infections.

Authors:  Cathrine Holm Olesen; Karima Brahimi; Brian Vandahl; Susana Lousada-Dietrich; Prajakta S Jogdand; Lasse S Vestergaard; Daniel Dodoo; Peter Højrup; Michael Christiansen; Severin Olesen Larsen; Subhash Singh; Michael Theisen
Journal:  Malar J       Date:  2010-10-26       Impact factor: 2.979

6.  Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection.

Authors:  P Deloron; B Dubois; J Y Le Hesran; D Riche; N Fievet; M Cornet; P Ringwald; M Cot
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

7.  Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria.

Authors:  Nnaemeka C Iriemenam; Christian M F Okafor; Halima A Balogun; Idowu Ayede; Yusuf Omosun; Jan-Olov Persson; Margareta Hagstedt; Chiaka I Anumudu; Roseangela I Nwuba; Marita Troye-Blomberg; Klavs Berzins
Journal:  Afr Health Sci       Date:  2009-06       Impact factor: 0.927

8.  Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.

Authors:  Lilian Rose Pratt-Riccio; Daiana De Souza Perce-Da-Silva; Josué Da Costa Lima-Junior; Evelyn Kety Pratt Riccio; Marcelo Ribeiro-Alves; Fátima Santos; Mercia Arruda; Daniel Camus; Pierre Druilhe; Joseli Oliveira-Ferreira; Cláudio Tadeu Daniel-Ribeiro; Dalma Maria Banic
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

Review 9.  Experience and challenges from clinical trials with malaria vaccines in Africa.

Authors:  Grace Mwangoka; Bernhards Ogutu; Beverly Msambichaka; Tutu Mzee; Nahya Salim; Shubis Kafuruki; Maxmillian Mpina; Seif Shekalaghe; Marcel Tanner; Salim Abdulla
Journal:  Malar J       Date:  2013-03-04       Impact factor: 2.979

10.  Duality and complexity of allergic type inflammatory mechanisms in determining the outcome of malaria disease.

Authors:  Ulrich Blank; Salaheddine Mécheri
Journal:  Front Immunol       Date:  2011-12-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.